nodes	percent_of_prediction	percent_of_DWPC	metapath
Glipizide—PPARG—nephron—nephrolithiasis	0.0648	0.346	CbGeAlD
Glipizide—CYP2C9—urine—nephrolithiasis	0.0305	0.162	CbGeAlD
Glipizide—Jaundice cholestatic—Hydrochlorothiazide—nephrolithiasis	0.0285	0.0351	CcSEcCtD
Glipizide—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.0235	0.0289	CcSEcCtD
Glipizide—CYP3A4—urine—nephrolithiasis	0.0232	0.124	CbGeAlD
Glipizide—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.0226	0.0279	CcSEcCtD
Glipizide—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.0207	0.0255	CcSEcCtD
Glipizide—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.0201	0.0248	CcSEcCtD
Glipizide—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.0196	0.0241	CcSEcCtD
Glipizide—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.0192	0.0236	CcSEcCtD
Glipizide—Thirst—Hydrochlorothiazide—nephrolithiasis	0.0191	0.0235	CcSEcCtD
Glipizide—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.0183	0.0225	CcSEcCtD
Glipizide—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.0182	0.0224	CcSEcCtD
Glipizide—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.018	0.0222	CcSEcCtD
Glipizide—Migraine—Hydrochlorothiazide—nephrolithiasis	0.0179	0.022	CcSEcCtD
Glipizide—ABCC8—renal system—nephrolithiasis	0.0167	0.0889	CbGeAlD
Glipizide—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.0166	0.0204	CcSEcCtD
Glipizide—ABCC8—kidney—nephrolithiasis	0.0161	0.0859	CbGeAlD
Glipizide—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.0147	0.0181	CcSEcCtD
Glipizide—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.0143	0.0177	CcSEcCtD
Glipizide—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.0137	0.0168	CcSEcCtD
Glipizide—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.0136	0.0168	CcSEcCtD
Glipizide—Sweating—Hydrochlorothiazide—nephrolithiasis	0.0134	0.0165	CcSEcCtD
Glipizide—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.0131	0.0161	CcSEcCtD
Glipizide—PPARG—renal system—nephrolithiasis	0.0127	0.0679	CbGeAlD
Glipizide—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.0126	0.0155	CcSEcCtD
Glipizide—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.0126	0.0155	CcSEcCtD
Glipizide—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.0125	0.0154	CcSEcCtD
Glipizide—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.0125	0.0154	CcSEcCtD
Glipizide—PPARG—kidney—nephrolithiasis	0.0123	0.0656	CbGeAlD
Glipizide—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.0121	0.0149	CcSEcCtD
Glipizide—Flushing—Hydrochlorothiazide—nephrolithiasis	0.0117	0.0144	CcSEcCtD
Glipizide—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0138	CcSEcCtD
Glipizide—Erythema—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0135	CcSEcCtD
Glipizide—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.0108	0.0133	CcSEcCtD
Glipizide—Tension—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0132	CcSEcCtD
Glipizide—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0131	CcSEcCtD
Glipizide—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.0105	0.013	CcSEcCtD
Glipizide—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0127	CcSEcCtD
Glipizide—Tremor—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0126	CcSEcCtD
Glipizide—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0125	CcSEcCtD
Glipizide—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00987	0.0122	CcSEcCtD
Glipizide—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00984	0.0121	CcSEcCtD
Glipizide—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00982	0.0121	CcSEcCtD
Glipizide—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.0098	0.0121	CcSEcCtD
Glipizide—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00962	0.0118	CcSEcCtD
Glipizide—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00932	0.0115	CcSEcCtD
Glipizide—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00932	0.0115	CcSEcCtD
Glipizide—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00929	0.0114	CcSEcCtD
Glipizide—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00921	0.0113	CcSEcCtD
Glipizide—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00901	0.0111	CcSEcCtD
Glipizide—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00893	0.011	CcSEcCtD
Glipizide—Shock—Hydrochlorothiazide—nephrolithiasis	0.00879	0.0108	CcSEcCtD
Glipizide—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00875	0.0108	CcSEcCtD
Glipizide—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00864	0.0106	CcSEcCtD
Glipizide—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00852	0.0105	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00814	0.01	CcSEcCtD
Glipizide—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00808	0.00995	CcSEcCtD
Glipizide—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00802	0.00987	CcSEcCtD
Glipizide—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00797	0.0098	CcSEcCtD
Glipizide—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00794	0.00978	CcSEcCtD
Glipizide—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00786	0.00968	CcSEcCtD
Glipizide—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00777	0.00956	CcSEcCtD
Glipizide—Pain—Hydrochlorothiazide—nephrolithiasis	0.00764	0.0094	CcSEcCtD
Glipizide—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00764	0.0094	CcSEcCtD
Glipizide—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00736	0.00906	CcSEcCtD
Glipizide—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00731	0.00899	CcSEcCtD
Glipizide—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.0071	0.00874	CcSEcCtD
Glipizide—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00706	0.00869	CcSEcCtD
Glipizide—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00658	0.0081	CcSEcCtD
Glipizide—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00641	0.00789	CcSEcCtD
Glipizide—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00632	0.00778	CcSEcCtD
Glipizide—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00611	0.00752	CcSEcCtD
Glipizide—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00591	0.00727	CcSEcCtD
Glipizide—CYP3A4—renal system—nephrolithiasis	0.00568	0.0303	CbGeAlD
Glipizide—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00568	0.00699	CcSEcCtD
Glipizide—Rash—Hydrochlorothiazide—nephrolithiasis	0.00563	0.00693	CcSEcCtD
Glipizide—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00563	0.00693	CcSEcCtD
Glipizide—Headache—Hydrochlorothiazide—nephrolithiasis	0.0056	0.00689	CcSEcCtD
Glipizide—CYP3A4—kidney—nephrolithiasis	0.00549	0.0293	CbGeAlD
Glipizide—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00531	0.00653	CcSEcCtD
